Serzone-5HT2 will go off the market this month in Canada

Serzone-5HT2 will go off the market this month in Canada.

Most, if not all, generic nefazodone products will follow.

So far, Health Canada hasn't mandated this. Nefazodone is associated with liver failure...liver transplants...even death.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote